ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 258 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,933,000 | -7.9% | 150,001 | +5.5% | 5.37% | -19.5% |
| Q2 2021 | $9,701,000 | -14.3% | 142,246 | -12.8% | 6.67% | +13.9% |
| Q1 2021 | $11,320,000 | +45.5% | 163,135 | +61.1% | 5.86% | +65.1% |
| Q4 2020 | $7,779,000 | +11.5% | 101,245 | +8.5% | 3.55% | -20.9% |
| Q3 2020 | $6,979,000 | -35.9% | 93,308 | -46.0% | 4.49% | -46.2% |
| Q2 2020 | $10,884,000 | +3.7% | 172,896 | -30.8% | 8.34% | -27.3% |
| Q1 2020 | $10,494,000 | +441.2% | 249,866 | +485.3% | 11.48% | +230.3% |
| Q4 2019 | $1,939,000 | +160.3% | 42,688 | +162.3% | 3.48% | +117.6% |
| Q3 2019 | $745,000 | – | 16,272 | – | 1.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |